Assessing Eligibility for Anticancer Drug Health Insurance Reimbursement Using Large Language Models: Benchmark Development and Comparative Study
Assessing Eligibility for Anticancer Drug Health Insurance Reimbursement Using Large Language Models: Benchmark Development and Comparative Study
Junhyuk Seo
1
* , RN, MS ;
Taerim Kim
1, 2, 3
* , MD, PhD ;
Ju-Hyun Kim
4
, MD, PhD
1
Healthcare Research Institute, ETOILE Inc, Seoul, Republic of Korea
2
Department of Digital Health, Samsung Advanced Institute of Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, Republic of Korea
3
Department of Emergency Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea
4
Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea
*these authors contributed equally
Corresponding Author:
-
Ju-Hyun Kim, MD, PhD
-
Department of Obstetrics and Gynecology
-
University of Ulsan College of Medicine, Asan Medical Center
-
88, Olympic-ro 43-gil, Songpa-gu
-
Seoul 05505
-
Republic of Korea
-
Phone:
82 10-9668-6227
-
Email: smilekako@naver.com